Compare the 9 manufacturers holding an active US Drug Master File for Desmopressin API, with DMF numbers and filing years from the FDA's quarterly DMF list.
Directory listing last reviewed October 2026.
9 manufacturers hold an active Type II Drug Master File for DesmopressinAPI, taken from the FDA's quarterly DMF list. A DMF lets a drug applicant reference the maker's manufacturing data. It is not an FDA approval. Check each manufacturer against the FDA import alert lists before ordering.
| Manufacturer | Location | US DMF | Filed |
|---|---|---|---|
| PolyPeptide Group | Global | 8396, 23676 | 1990 |
| Aspen API (Aspen Oss) | Netherlands | 10175 | 1993 |
| TAPI (Teva API) / Novetide | Israel / Global | 16947 | 2003 |
| BCN Peptides | Spain (Barcelona) | 19334 | 2006 |
| Piramal Pharma Solutions | India (Mumbai) | 22871 | 2009 |
| Auro Peptides | India (Hyderabad) | 30233 | 2016 |
| Hybio Pharmaceutical | China | 31889 | 2017 |
| Sinopep Biopharma | China | 37799 | 2023 |
| Shilpa PharmaFDA import alert | India | 43522 | 2026 |
Request API quotes from several manufacturers at once.